The US Food and Drug Administration (FDA) has approved a non-opioid drug for severe post-surgical pain, which could “redefine ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

Under this condition, which can result from traumatic injuries, infections, metabolic problems, or could be inherited due to ...

Mumbai reported its first case of Guillain-Barre Syndrome with a 64-year-old woman diagnosed. Maharashtra has seen at least ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

1Sanford Research, Cancer Biology and Immunotherapies Group, Sioux Falls, South Dakota. 2Sanford School of Medicine, Health Sciences Center, University of South Dakota, Sioux Falls, South Dakota.

Journavx (suzetrigine) is said to reduce pin by "targeting a pain-signaling pathway involving sodium channels in the ...

Doctors from the Cleveland Clinic talk about how this new non-opioid pain medication could help reduce the issue of opioid ...

Maharashtra reports a significant increase in Guillain-Barre Syndrome cases, with 170 suspected and 132 confirmed. State ...

Diseases of the nervous system refer to disorders that affect any part of the central nervous system (brain, spinal cord or cranial nerves) or peripheral nervous system. Rabah et al. elegantly ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...